The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3

Oct 8, 2024
1 min read

Click here to learn more and register!

Recent Posts

Advocate for Cancer Care and the Oncology Nursing Workforce

Advocate for Cancer Care and the Oncology Nursing Workforce Bring your voice and your expertise to Washington, DC. For nearly a decade, ONS Capitol Hill Days have empowered oncology nurses to advocate

A New Treatment Approach for Cisplatin-Ineligible Patients with MICB*

New Event! Program on ZEPZELCA

Comments